![Michèle Ollier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michèle Ollier
Direttore/Membro del Consiglio presso
IPSEN
Patrimonio netto: 92 406 $ in data 31/03/2026
Profilo
Michèle Ollier is the founder of Medicxi Ventures (Jersey) Ltd., founded in 2016, holding the title of Senior Advisor.
Current jobs include Chief Executive Officer at Kaerus Bioscience France SASU since 2017; Independent Director at Ipsen SA since 2015; Director at LinguaFlex, Inc., Palladio Biosciences, Inc., Kaerus Bioscience Ltd., Aldena Therapeutics, Inc., Vimela Therapeutics Ltd., and Medicxi Ventures (Jersey) Ltd. (Switzerland); Director at Mavalon Therapeutics Ltd. since 2016; and Partner at Medicxi Ventures (Jersey) Ltd. (Switzerland).
Former jobs include Chairman at Funxional Therapeutics Ltd. and Mind-NRG SARL; Director at Aegerion Pharmaceuticals, Inc. from 2007 to 2011; Director at NormOxys, Inc., Diasome Pharmaceuticals, Inc., Oncoethix GmbH, Cyrenaic Pharmaceuticals, Inc. from 2010 to 2014, Profibrix BV, Sonkei Pharmaceuticals, Inc., EnCare Biotech BV, Stx Pharma Ltd., Gadeta BV, Kymo Therapeutics Ltd., Abtco BV, Yukin Therapeutics SAS, Pearl River Bio GmbH, Pega-One SAS, Nira Biosciences, Inc., Mavalon Therapeutics France SAS, Epsilon-3 Bio Ltd, Human Antibody Factory Ltd., Villaris Therapeutics, Inc.; Independent Director at Minerva Neurosciences, Inc. from 2014 to 2017; Manager-CNS Product at Sanofi in 1989; Vice President-International Reproductive Health at Serono SA from 2000 to 2002; Partner at Index Ventures SA from 2009 to 2016; and Group Director-Lipid Lowering Agents at Bristol-Myers Squibb SARL from 1989 to 1992; Director-International Oncology at Rhone-Poulenc Rorer, Inc. in 2000.
Education includes a doctorate from Université Paris Nanterre.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IPSEN SA 0% | 31/12/2024 | 500 ( 0% ) | 92 406 $ | 31/03/2026 |
Posizioni attive di Michèle Ollier
| Società | Posizione | Inizio |
|---|---|---|
| IPSEN | Direttore/Membro del Consiglio | 27/05/2015 |
Kaerus Bioscience France SASU
 Kaerus Bioscience France SASU Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Amministratore Delegato | 10/10/2017 |
Vimela Therapeutics Ltd. | Direttore/Membro del Consiglio | - |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Direttore/Membro del Consiglio | - |
Kaerus Bioscience Ltd.
 Kaerus Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics for rare neurodevelopmental disorders | Direttore/Membro del Consiglio | - |
Mavalon Therapeutics Ltd.
 Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients | Direttore/Membro del Consiglio | 22/02/2016 |
Medicxi Ventures (Jersey) Ltd. (Switzerland) | Corporate Officer/Principal | - |
LinguaFlex, Inc.
 LinguaFlex, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical devices for the treatment of sleep apnea | Direttore/Membro del Consiglio | - |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Fondatore | 01/01/2016 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Michèle Ollier
| Società | Posizione | Fine |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Michèle Ollier
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
39
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 39 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes | Health Technology |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures invests companies across the globe. The firm target companies operating across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partner invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Finance |
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which develops cancer drugs | Health Technology |
Funxional Therapeutics Ltd.
 Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Health Technology |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Provides pharmaceutical and health care products | Distribution Services |
LinguaFlex, Inc.
LinguaFlex, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical devices for the treatment of sleep apnea | Health Technology |
Cyrenaic Pharmaceuticals, Inc.
 Cyrenaic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides and develops drugs | Health Technology |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Sonkei Pharmaceuticals, Inc.
 Sonkei Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for depression and mood disorders | Health Technology |
Université Paris Nanterre
 Université Paris Nanterre Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Provides compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders | Health Technology |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
EnCare Biotech BV
 EnCare Biotech BV Medical/Nursing ServicesHealth Services Operates as a biopharmaceutical company | Health Services |
Stx Pharma Ltd. | |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Operates as cell therapy company developing treatments based on g/d T cell receptors for targeting solid tumors | Health Technology |
Kymo Therapeutics Ltd.
 Kymo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
Abtco BV
 Abtco BV Packaged SoftwareTechnology Services Offers platform to develop receptors for T cell engineering in oncology with advantages on efficacy and intellectual property position | Technology Services |
Mavalon Therapeutics Ltd.
Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients | Health Technology |
Kaerus Bioscience France SASU
Kaerus Bioscience France SASU Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Human Antibody Factory Ltd.
 Human Antibody Factory Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
Yukin Therapeutics SAS
 Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Kaerus Bioscience Ltd.
Kaerus Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics for rare neurodevelopmental disorders | Commercial Services |
Villaris Therapeutics, Inc.
 Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an asset-centric biopharmaceutical company | Health Technology |
Pearl River Bio GmbH | |
Pega-One SAS | |
Medicxi Ventures (Jersey) Ltd. (Switzerland) | |
Nira Biosciences, Inc. | |
ALDENA THERAPEUTICS, INC.
 ALDENA THERAPEUTICS, INC. BiotechnologyHealth Technology Operates as a biotechnology company focused on immuno-dermatology research and drug development | Health Technology |
Vimela Therapeutics Ltd. |
